Cpia de How to link Social Media to the 3D Artificial Intelligence driven menu – Video


Cpia de How to link Social Media to the 3D Artificial Intelligence driven menu
http://bynatal.net/internet/marketing/ In terms of Search Engine Optimisation the links from and to Social Media Websites, such as Youtube, Google+, Facebook and others do have a relevance...

By: Ioeti Services Ltda

Continued here:

Cpia de How to link Social Media to the 3D Artificial Intelligence driven menu - Video

Anti-Artificial Intelligence Protests Begin – SXSW – South by Southwest Protest by StopTheRobots.org – Video


Anti-Artificial Intelligence Protests Begin - SXSW - South by Southwest Protest by StopTheRobots.org
Anti-Artificial Intelligence Protests Begin - SXSW - South by Southwest Protest by StopTheRobots.org *SUBSCRIBE* for more great videos daily and sound off in the comments section by sharing...

By: Mark Dice

Link:

Anti-Artificial Intelligence Protests Begin - SXSW - South by Southwest Protest by StopTheRobots.org - Video

03-17-15 NPR / WBUR: Framingham Startup Uses Artificial Intelligence To Find Cancer Drugs – Video


03-17-15 NPR / WBUR: Framingham Startup Uses Artificial Intelligence To Find Cancer Drugs
NPR #39;s Curt Nickisch talks to Berg about our approach to drug discovery utilizing artificial intelligence and our cancer therapeutic candidate BPM31510.

By: Berg LLC

Read more here:

03-17-15 NPR / WBUR: Framingham Startup Uses Artificial Intelligence To Find Cancer Drugs - Video

Interview with Dr. Venable, Tulane University Department of Computer Science – Video


Interview with Dr. Venable, Tulane University Department of Computer Science
K. Brent Venable currently holds a joint appointment as associate professor of computer science at Tulane University and research scientist at IHMC. Her main research interests are within artificia...

By: Tulane University

Original post:

Interview with Dr. Venable, Tulane University Department of Computer Science - Video

It’s Okay (One Blood) vs. No Return (The Game vs. Artificial Intelligence) | DJ HERO 3 – Video


It #39;s Okay (One Blood) vs. No Return (The Game vs. Artificial Intelligence) | DJ HERO 3
MIX: It #39;s Okay (One Blood) vs. No Return ARTIST(S): The Game vs. Artificial Intelligence TYPE OF MIX: DJ Only BPM: 130.00 COMPLEXITY: 9/10 (Ridiculous) TAPS: 6/10 (Hard) CROSSFADES: 8/10 ...

By: CMCroom the DJ Hero

The rest is here:

It's Okay (One Blood) vs. No Return (The Game vs. Artificial Intelligence) | DJ HERO 3 - Video

Google's FaceNet facial recognition claims to be the best yet

Three Google researchers have published a paper on a new artificial intelligence system called FaceNet, that they claim is one of the most-accurate ways of identifying human faces.

The Google researchers, Florian Schroff, Dmitry Kalenichenko and James Philbin, say that their system achieved a new record accuracy of 99.63 per cent on the widely used Labeled Faces in the Wild (LFW) dataset. On YouTube Faces DB it achieved 95.12 per cent. "Our system cuts the error rate in comparison to the best published result by 30 per cent on both datasets," the paper claims.

Facial recognition is a high-interest area for both companies and governments alike. In 2014, researchers from Facebook had published a paper claiming more than 97 per cent accuracy in recognising faces. Another group of Chinese researchers claimed better than 99 per cent accuracy, according to a report on Fortune.

Google researchers have published a paper on a new artificial intelligence system called FaceNet, that they claim is one of the most-accurate ways of identifying human faces. (Facial recognition, via Shutterstock)

These systems incorporate an artificial intelligence technique called deep learning and also includes recognising voices and understanding the content of written text.

Aside from Google and Facebook, companies including Microsoft, Baidu, and Yahoo are also investing heavily in deep learning research, says the Fortune report. The US Department of Defence's research agency DARPA, is also looking at ways in which deep learning techniques could be able to help it make sense of the massive streams of communications crossing intelligence networks.

More here:

Google's FaceNet facial recognition claims to be the best yet

U.S. Air Force: Bioastronautics Research | Aerospace Medical Research Lab – Video


U.S. Air Force: Bioastronautics Research | Aerospace Medical Research Lab
Summary: Coverage of research at the Aerospace Medical Division Hq 657Oth Aerospace Medical Research Laboratories including scenes of F-104 seat ejection; drop tests from C-130 and ejection...

By: Motion Vault

Go here to see the original:

U.S. Air Force: Bioastronautics Research | Aerospace Medical Research Lab - Video

Beckwood Installs Large-Format Triform Fluid Cell Sheet Hydroforming Press At Aerospace Manufacturer

Beckwood, manufacturer of advanced hydraulic press solutions and the Triform line of aerospace focused forming machinery, is proud to announce the installation of a 24 x 96 Fluid Cell sheet hydroforming press within the aircraft manufacturing facility of a US-headquartered company.

St. Louis, MO (PRWEB) - Beckwood, manufacturer of advanced hydraulic press solutions and the Triform line of aerospace focused forming machinery, is proud to announce the installation of a 24 x 96 Fluid Cell sheet hydroforming press within the aircraft manufacturing facility of a US-headquartered company.

The Triform, Model 2496-5BD, has a specific appeal to industries and operations involved with forming a variety of part sizes in low volume, high mix environments. The 2496-5BD offers a maximum of 5000 PSI of evenly distributed forming pressure which can be used to form a variety of parts using the low-cost tooling associated with the Triform process. The press is offered with either a single bed shuttle, or dual shuttles with front and rear control stations for increased productivity.

Aircraft manufacturers are learning the advantages of our Triform 2496-5BD, including its ability to accommodate a significant percentage of their aerospace parts, said Beckwoods President, Jeffrey Debus. Companies forming aerospace ribs, panels, trim pieces, brackets and more will appreciate the versatility the 2496-5BD offers. Additionally, manufacturers currently using traditional press brakes to form multiple bends in a single part, through several operations, will benefit from a consolidation of process steps and overall manufacturing time, by transitioning those parts over to the Triform process, continued Debus.

Like its counterparts in the Triform forming equipment family, the 2496-5BD is fully programmable, designed for simple operation and features a structure which is engineered for Infinite Life. It features programmable pressure, on-board diagnostics, multi-level password protection, and a compact design for flush floor operation. The Triform is also exceedingly durable with low maintenance requirements including fast bladder changes which require approximately 2 hours to complete, and standard, catalogued components from premium suppliers.

This particular Triform model features an OEE, or Overall Equipment Effectiveness system, for maximizing the users manufacturing productivity, Debus continued. Triforms OEE system helps management identify production problems fast, through real-time monitoring of various criteria, including machine status, shift performance data, labor productivity tracking and more, he concluded.

The Triform 2496-5BD features a variable frequency drive (VFD) to maximize energy efficiency by varying the motors speed & torque, based on actual demand requirements. Additional benefits of the integrated VFD system include reduced noise levels and a reduction in the operating temperature of the presses, thereby minimizing the on-board cooling requirements.

In addition to the Triform Model 2496-5BD, Beckwood offers an entire line of aerospace forming equipment, including several other Fluid Cell sheet hydroforming models, a full line of Deep Draw sheet hydroforming models, extrusion and sheet / leading edge stretch forming machines, hot joggle presses and more.

About Beckwood Press Company The Beckwood Press Company is a leading hydraulic press supplier, located in St. Louis, MO USA. They offer quality, custom hydraulic presses for virtually every industry & application, including a line of high-temperature hot forming / SPF presses for forming structural aerospace components. Beckwood also manufactures the Triform line of Sheet Hydroforming Presses in both fluid cell and deep draw models, hydraulic ring expanders / sizers, hot joggle presses, as well as a line of stretch forming machines for both extrusion, sheet and leading edge applications. Get the latest news from Beckwood at http://www.beckwoodpress.com/news.

Go here to read the rest:

Beckwood Installs Large-Format Triform Fluid Cell Sheet Hydroforming Press At Aerospace Manufacturer

Nanobiotix Appoints Its Manufacturing Partner, CordenPharma: Another Step Towards Commercialization

NANOBIOTIX (Paris:NANO) (Euronext: NANO ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces it has appointed CordenPharma as its manufacturing partner. The opening of a new manufacturing line and the scaling up of production is an important step in NBTXR3s route to commercialization.

The new manufacturing line, located in France, will increase the amount of NBTXR3 product available. With an anticipated award of a CE mark in 2016, the Company is preparing to scale-up production further to meet the needs of future commercialization. Furthermore, Nanobiotix is anticipating future demand from clinical trials in the coming years in Europe and in the United States.

CordenPharma is an international full service CMO (contract manufacturing organization) which provides specialized technologies for the development and manufacture of health products. The company is recognized by EMA and FDA thanks to its eight cGMP facilities across Europe and the United States and works with both pharma and biotech companies. Its facilities are regularly inspected by the regulatory authorities (FDA and EMA) and have a good track record.

Laurent Lvy, Chief Executive Officer at Nanobiotix, commented: Finding the right manufacturing partner is essential, since ensuring quality and sufficient levels of supply is fundamental for meeting the market demands and the growth of the Company.

Yves Michon, Prsident Synkem - CordenPharma said: Nanobiotixs product, NBTXR3 is a fascinating product not only with respect to its properties, but also in its manufacture. We are working closely with Nanobiotix to ensure a seamless process and manage the scale-up of the product.

NBTXR3 is Nanobiotixs lead product in the NanoXray portfolio. The product comprises Hafnium Oxide nanoparticles which can be injected directly into tumor. With the application of radiotherapy, these nanoparticles absorb X-rays have the potential to significantly enhances the radiation dose within the cancer cells without increasing the dose to the surrounding healthy tissues. NBTXR3 has the potential to cause a paradigm shift in cancer therapy with significant clinical benefit for patients.

In November 2014, Nanobiotix announced its global clinical development plan. In addition to Soft Tissue Sarcoma and Head and Neck cancer, the plan now includes metastatic liver cancer, hepatocellular carcinomas and prostate cancer. In the second half of 2015, the liver cancers and high risk prostate cancer programs are anticipated to enter the clinical stage.

About NANOBIOTIX: http://www.nanobiotix.com

Nanobiotix (Euronext: NANO / ISIN: FR0011341205) is a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer. The companys first-in-class, proprietary technology, NanoXray, enhances radiotherapy energy with a view to provide a new, more efficient treatment for cancer patients. NanoXray products are compatible with current radiotherapy treatments and are meant to treat potentially a wide variety of cancers including Soft Tissue Sarcoma, Head and Neck Cancer, Liver Cancers, Prostate Cancer, Breast Cancer, Glioblastoma, etc., via multiple routes of administration.

Nanobiotixs lead product NBTXR3, based on NanoXray, is currently under clinical development for Soft Tissue Sarcoma and locally advanced Head and Neck Cancer. The company has partnered with PharmaEngine for clinical development and commercialization of NBTXR3 in Asia.

See the rest here:
Nanobiotix Appoints Its Manufacturing Partner, CordenPharma: Another Step Towards Commercialization